Clinical experience with Thera DR rate-drop response pacing algorithm in carotid sinus syndrome and vasovagal syncope

PACE - Pacing and Clinical Electrophysiology

Volumn 20, Issue 3 II, 1997, Pages 832-839

  Benditt, David G ^a   Sutton, Richard ^b   Gammage, Michael D ^c   Markowitz, Toby ^d   Gorski, Joanne ^d   Nygaard, Gary A ^d   Fetter, Joseph ^d  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^d MEDTRONIC INC   (United States)

Author keywords

Carotid sinus syndrome; Pacemaker; Vasovagal syncope

Indexed keywords

ADULT; AGED; ALGORITHM; CAROTID SINUS SYNDROME; CLINICAL ARTICLE; CONFERENCE PAPER; HEART PACING; HEART RATE; HUMAN; SYNCOPE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; BAROREFLEX; BLOOD PRESSURE; CARDIAC PACING, ARTIFICIAL; CAROTID SINUS; FOLLOW-UP STUDIES; HEART RATE; HUMANS; MIDDLE AGED; PACEMAKER, ARTIFICIAL; RECURRENCE; SENSITIVITY AND SPECIFICITY; SYNCOPE; SYNCOPE, VASOVAGAL; SYNDROME; TREATMENT OUTCOME;

EID: 17944400731     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.1997.tb03916.x     Document Type: Article

References (37)

1. Benditt DG, Goldstein MA, Adler S, et al. Neurally mediated syncopal syndromes: Pathophysiology and clinical evaluation. In WJ Mandel (ed.): Cardiac Arrhythmias. 3rd ed. Philadelphia, PA, J.B. Lippincott Co., 1995, pp. 879-906.
2. Kosinski DJ, Grubb BP. Neurally mediated syncope with an update on indications and usefulness of head-up tilt table testing and pharmacologic therapy. Curr Opin Cardiol 1994; 9:53-64.
3. Sugrue DD, Gersh BJ, Holmes DR, et al. Symptomatic "isolated" carotid sinus hypersensitivity: Natural history and results of treatment with anticholinergic drugs or pacemaker. J Am Coll Cardiol 1986; 7:158-162.
4. Almquist A, Gornick C, Benson DW Jr, et al. Carotid sinus hypersensitivity: Evaluation of the vasodepressor component. Circulation 1985; 71: 927-936.
5. Morley CA, Perrins EJ, Grant P, et al. Carotid sinus syncope treated by pacing. Analysis of persistent symptoms and role of atrioventricular sequential pacing. Br Heart J 1982; 47:411-418.
6. Morley CA, Perrins EJ, Chan SL, et al. Long-term comparison of DDI and VVI pacing in carotid sinus syndrome. In K Steinbach (ed.): Cardiac Pacing. Proceedings of the VIIth World Symposium on Cardiac Pacing. Steinkopff Verlag Darmstadt, 1983, pp. 929-935.
7. Madigan NP, Flaker GC, Curtis JJ, et al. Carotid sinus hypersensitivity: Beneficial effects of dual-chamber pacing. Am J Cardiol 1984; 53: 1034-1040.
8. Peretz DI, Abdulla A. Management of cardioinhibitory hypersensitive carotid sinus syncope with permanent cardiac pacing - a seventeen year prospective study. Can J Cardiol 1985; 2:86-91.
9. Styjer D, Friedensohn A, Schlesinger Z. Ventricular pacing as the preferable mode for long-term pacing in patients with carotid sinus syncope of the cardioinhibitory type. PACE 1986; 9:705-709.
10. Brignole M, Sartore B, Barra M, et al. Is DDD superior to VVI pacing in mixed carotid sinus syndrome? An acute and medium-term study. PACE 1910; 11:1902-1910.
11. Brignole M, Sartore B, Barra M, et al. Ventricular and dual chamber pacing for treatment of carotid sinus syndrome. PACE 1989; 12:582-590.
12. Brignole M, Menozzi C, Lolli G, et al. Pacing for carotid sinus syndrome and sick sinus syndrome. PACE 1990; 13:2071-2075.
13. Deschamps D, Richard A, Citron B, et al. Hypersensibilité sino-carotidienne. Evolution a moyen et a long terme des patients traites par stimulation ventriculaire. Arch Mal Coeur 1990; 83:63-67.
14. Almquist A, Goldenberg, Milstein S, et al. Provocation of bradycardia and hypotension by isoproterenol and upright posture in patients with unexplained syncope. N Engl J Med 1989; 320:346-351.
15. Blanc JJ, Boschat J, Penther PH. Hypersensibilité sino-carotidiene. Evolution a moyen terme en function du traitement et des symptomes. Arch Mal Coeur 1984; 77:330-335.
16. Milstein S, Buetikofer J, Dunnigan A, et al. Usefulness of disopyramide for prevention of upright tilt-induced hypotension-bradycardia. Am J Cardiol 1990; 65:1339-1344.
17. Fitzpatrick AP, Ahmed R, Williams S, et al. A randomized trial of medical therapy in "malignant vasovagal syndrome" or "neurally mediated bradycardia." Eur JCPE 1991; 2:99-102.
18. Nelson S, Stanley M, Love C, et al. The autonomic and hemodynamic effects of oral theophylline in patients with vasodepressor syncope. Arch Int Med 1991; 151:2425-2429.
19. Brignole M, Menozzi C, Gianfranchi L, et al. A controlled trial of acute and long-term medical therapy in tilt-induced neurally mediated syncope. Am J Cardiol 1992; 70:339-342.
20. Sra JS, Murphy VS, Iazayeri MR, et al. Use of intravenous osmolal to predict efficacy of oral adrenergic blocker therapy in patients with neurocardiogenic syncope. J Am Coll Cardiol 1993; 19:402-408.
21. Morillo C, Leitch JW, Yee R, et al. A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt. J Am Coll Cardiol 1993; 22: 1843-1848.
22. Grubb BP, Wolfe D, Samiol D, et al. A placebo controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt. PACE 1993; 16:458-464.
23. Kosinski DJ, Grubb BP, Temesy-Armos PN. The use of serotonin re-uptake inhibitors in the treatment of neurally mediated cardiovascular disorders. J Serotonin Res 1994; 1:85-90.
24. Mahanonda N, Bhuripanyo K, Kangkagate C, et al. Randomized double-blind placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt table results. Am Heart J 1995; 130:1250-1253.
25. Jankovic J, Hiner BC, Brown DC, et al. Neurogenic orthostatic hypotension: A double-blind placebo-controlled study with midodrine.
26. Sapire DW, Casta A, Safley W, et al. Vasovagal syncope in children requiring pacemaker implantation. Am Heart J 1983; 106:1406-1411.
27. Fitzpatrick A, Theodorakis G, Ahmed R, et al. Dual chamber pacing aborts vasovagal syncope induced by head-up 60 tilt. PACE 1991; 13:13-19.
28. Kus T, Lalonde G, De Champlain J, et al. Management with atrioventricular sequential pacing and beta-blockade. Can J Cardiol 1989; 5:375-378.
29. Perry J, Friedman RA, Moak JP, et al. Bradycardia and syncope in children not controlled by pacing: Beta-adrenergic hypersensitivity. PACE 1991; 14: 391-394.
30. Kosinski DJ, Grubb BP, Elliott L, et al. Treatment of malignant neurocardiogenic syncope with dual chamber cardiac pacing and fluoxetine hydrochloride. PACE 1995; 18:1455-1457.
31. Benditt DG, Petersen M, Lurie KG, et al. Cardiac pacing for prevention of recurrent vasovagal syncope. Ann Int Med 1995; 122:204-209.
32. Samoil D, Grubb BP, Brewster P, et al. Comparison of single and dual chamber pacing techniques in prevention of upright tilt-induced vasovagal syncope. Eur JCPE 1993; 1:36-41.
33. Sra J, Jazayeri MR, Avitall B, et al. Comparison of cardiac pacing with drug therapy in the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asystole. N Engl J Med 1993; 328: 1085-1090.
34. Petersen MEV, Chamberlain-Webber R, Fitzpatrick AP, et al. Permanent pacing for cardio-inhibitory malignant vasovagal syndrome. Br Heart J 1994; 71: 274-281.
35. Gammage MD, Hess M, Markowitz T. Initial experience with a rate drop algorithm in malignant vasovagal syndrome. Eur JCPE 1995; 5:45-48.
36. Zhu W-X, Rizo-Patron C, Berrier HB, et al. Value of dual chamber pacemakers with rate drop response/search hysteresis in the management of vasovagal syncope and carotid sinus hypersensitivity. (abstract) PACE 1995; 18:907.
37. Petersen M, Hess M, Markowitz T, et al. Acute Human investigation of an algorithm to treat vasovagal syncope using a computer based simulator. (abstract) PACE 1995; 18(Pt. II):825.